Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Loquat Leaf Syrup (Fufang Pipaye Tangjiang) is a traditional Chinese medicine (TCM) manufactured by Guiyang Dechangxiang Pharmaceutical. It is an oral liquid formulation primarily indicated for the treatment of cough, excessive phlegm, and dry throat, particularly those associated with wind-heat type common cold or bronchitis. The preparation is a combination of several herbal ingredients, typically including loquat leaf (Eriobotrya japonica), mulberry bark (Morus alba), platycodon root (Platycodon grandiflorus), and menthol. These components work synergistically to clear lung heat, moisten the respiratory tract, and promote the discharge of phlegm. The product is officially approved and marketed in China, adhering to the standards of the Chinese Pharmacopoeia.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound loquat leaf syrup.